Following are the Top 5 companies based on their one-day percentage change within the 'Disruptive Tech ETFs' theme.Global X - Internet of Things ETF (SNSR)SNSR is trading UP for the last 1 days, and it at trading at $49.61 with volume of 9,834 and a one day change of $0.49 (0.99%). Global X - Internet...
from H.C. Wainwright issued a price target of $38.00 for BDSX on 2026-09-25 16:29:02.The adjusted price...
H.C. Wainwright analyst issues BUY recommendation for BDSX on September 25, 2026 04:29PM ET. The previous...
IperionX Limited (IPX) confirmed earnings release on September 25, 2026, Before the market for the quarter...
Inventiva S.A. (IVA) confirmed earnings release on September 25, 2026, After the market for the quarter...
from H.C. Wainwright issued a price target of $38.00 for BDSX on 2026-09-25 16:29:02.The adjusted price target was set to $38.00.At the time of the announcement, BDSX was trading at...
Jonathan Siegmann from Stifel Nicolaus issued a price target of $6.50 for KOPN on 2026-09-25 13:12:00.The adjusted price target was set to $6.50.At the time of the announcement, KOPN was...
from UBS issued a price target of $2.00 for TELA on 2026-09-25 12:50:21.The adjusted price target was set to $2.00.At the time of the announcement, TELA was trading at $1.275.The...
Erin Wright from Morgan Stanley issued a price target of $1.40 for PETS on 2026-09-25 12:19:32.The adjusted price target was set to $1.40.At the time of the announcement, PETS was...
David Smith from Truist Financial issued a price target of $172.00 for BNY on 2026-09-25 11:41:51.The adjusted price target was set to $172.00.At the time of the announcement, BNY was...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
